NL
DE
25 July 2018
Eva-Leonne Göttgens, PhD candidate at the Radiotherapy and OncoImmunology laboratory (ROI), theme Rare cancers, has received an Early Career Investigator Award during the annual meeting of the Association for Radiation Research 2018 in Belfast.
She presented the results of her collaboration with the Oxford Institute for Radiation Oncology and the ROI laboratory, which included new radiosensitising treatment strategies for head and neck squamous cell carcinomas.
Eva-Leonne is member within the theme Rare cancers.
Related news items
Combining targeted radionuclide therapy and immune checkpoint inhibition for cancer treatment
4 May 2022 Simone Kleinendorst, Sandra Heskamp and colleagues, theme Rare cancers, published in Clinical Cancer Research about their research on combined radionuclide therapy and immunotherapy for cancer treatment. read more
RIMLS awards call for nominations
19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more
Tackling cancer with radioactive particles
2 September 2021 Professor Sandra Heskamp receives grant for research into cancer treatment with radioactivity read more
Miniaturized microfluidic platform for automated epigenetic profiling
6 May 2021 Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies. read more
Increase radio- and immunotherapy efficacy by targeting hypoxia
21 January 2021 In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors. read more
